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Poisoning in the Pediatric 
Intensive Care Unit
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Abstract
Poisonings during childhood (both accidental and voluntary) are a common 
cause of presentation in the emergency departments (EDs) and the pediatric 
intensive care unit (PICU). The admission to PICU is warranted both for treatment 
and for continuous monitoring, as sometimes the evolution of a poisoning could 
be unpredictable. Sometimes, complications arise that may prolong the patients’ 
hospitalization and may contribute to lowering the survival rate. The staff in these 
departments must be well trained to ensure patient monitoring, early detection of 
complications, and rapid intervention. Supporting vital functions is the main objec-
tive of the management of a poisoned patient admitted in PICU. In recent years, 
staff competence and advanced medical technology have helped to improve the 
prognosis of the patients admitted to these departments, including of the poisoned 
patients.
Keywords: intensive care, poisoning, children
1. Introduction
Poisoning is a relatively common medical emergency worldwide and raises 
particular problems of diagnosis and treatment especially in children, regard-
less of the path the toxic enters the body (ingestion, inhalation, injection, or skin 
absorption). This age group is the most vulnerable population with the highest 
risk of accidental intoxications that can be partially prevented [1]. It is a common 
cause of presentation in the ED and the PICU. Early identification of the clinical 
characteristics of patients with acute intoxication and rapid initiation of therapy 
in these services can help reduce the mortality of intoxicated patients [2, 3]. These 
departments have the ability to continuously monitor vital parameters, use the most 
advanced medical technology and the most appropriate treatment. Usually, admis-
sion to PICU is by ED or by transfer from another hospital [4]. Often, a poisoned 
patient will be brought into intensive care not for treatment, but for continuous 
surveillance and monitoring in order to minimize mortality. On the other hand, 
care in these units has a very high cost. It is therefore recommended that the admis-
sion of poisoning cases in intensive care should take into account the efficient use of 
resources without compromising patient care [5]. The percentage of children with 
acute poisoning in PICU ranges from 8% [6] to 11.7% [2]. In the United States in 
2014, 2336 intoxicated patients admitted to intensive care units needed ventilatory 
support, 509 received vasopressors, and 127 needed hemodialysis [4].
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2. Admission of intoxicated patients in PICU
There are several studies that attempt to establish criteria for admission to inten-
sive care in patients based on severity scores (APACHE II/III, PRISM II/III, SAPS II, 
Glasgow etc.). These included patients with various medical and surgical conditions, 
but few can be validated using such scoring systems in poisoned patients [7–9]. Until 
more specific poisoning factors are established, it is thought that experience and proper 
clinical judgment can predict which patients will receive intensive care. The presence 
of certain abnormal symptoms or abnormal test results may require monitoring and/or 
treatment in PICU regardless of the suspected toxic. This approach is more consistent 
with the principle of “treating the patient and not the poison” [5]. It should be kept 
in mind that an initially asymptomatic poisoned patient may worsen later. Poisoned 
children and adolescents should be directed to the nearest intensive care unit that has 
pediatric critical care practitioners and equipment appropriate to pediatric age.
2.1 Criteria for admission to intensive care of the poisoned patient
I.  Acute respiratory failure characterized by one or more of the following [4]:
• Need for ventilatory support or emergency tracheostomy.
• Marked respiratory compromise as indicated by:
a.  FR <20 or >60 for children <1 year and <12 or >60 for children >1 year.
b. SpO2 <92% when O2 is administrated by mask or tracheostomy.
c.  PaO2 <80 mm Hg at 100% O2 administrated by mask.
• Rapidly progressive deterioration in respiratory status.
• Respiratory acidosis with PaCO2 > 60 mmHg and pH < 7.25.
• Airway obstruction, apnea, anaphylaxis.
II.  Hemodynamic instability or circulatory insufficiency characterized by one 
or more of the following:
• Shock as indicated by capillary refill time >4 s, distal or proximal nonpalpa-
ble pulse, systolic TA < lower age limit or TA < mean 50 mmHg (<40 mmHg 
in newborn), metabolic acidosis with < pH 7.25, base deficit >10 or serum 
bicarbonate <10 mEq/l, need for invasive hemodynamic monitoring.
• Cardiac instability and arrhythmia, necessity of continuous perfusion or 
vasoactive substances, ECG ischemic changes, congestive heart failure, 
and vascular volume instability.
III.  Neurological instability manifested by one or more of the following:
• Neurological damage with one or more of the following: Glasgow 
score <10, severe irritability, hallucinations, and change of posture.
• Intracranial bleeding, increased intracranial pressure, seizures, or delirium.
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IV.  Severe metabolic disorders: serum Na <125 mmol/l or >160 mmol/l, serum 
K <3 mmol/l or >6.5 mmol/l, glucose <30 mg/dl or >400 mg/dl, ionic calcium 
<0.8 mEq/l, base deficit >−10.
V.  Other patients at risk of organ failure or system failure.
VI.  Toxic exposed patients in which none of the above are present but:
• Within a few hours, one of the above criteria is expected.
• Suicide patient that cannot be monitored in other unit care.
3. Specific monitoring and treatment in PICU
The main concern in the management of a patient with acute intoxication in 
PICU is the support of the vital functions. The general measures in a poisoned 
patient do not differ significantly from those required in a patient admitted to PICU 
with similar symptoms and a comparable level of severity but with pathology [4]. 
These critically intoxicated patients should be rapidly recognized by the clinician 
and evaluated for appropriate therapy. Continuous follow-up of vital functions, 
neurological status, blood volume, and heart rate makes possible early detection of 
poisoning worsening signs requiring rapid intervention to prevent complications [5]. 
Advanced medical technology in PICU offers a number of invasive and noninvasive 
options that can trigger an early warning of rapid deterioration or provide feedback 
about the response to treatment. For example, monitoring hemodynamic parameters 
are valuable for managing poisoned patients with hypotension, volume depletion, or 
respiratory failure from acute lung injury (ALI). Most importantly, clinicians need to 
recognize that no monitoring device improves clinical outcome unless is completed 
by a treatment.
Some antidotes and specific therapies are initiated in ED and continued in PICU, 
which is the most appropriate place to administer or continue treatment. In addi-
tion to conventional therapies, PICU’s medical practitioners also know how to deal 
with situations that do not look like treatment protocols. For example, high doses of 
atropine, like hundreds of milligrams, can be used to treat organophosphate insec-
ticides [5, 10]. Sometimes the antidote has less effect than the toxin. For example, 
opioid-intoxicated coma patients responding to naloxone are rapidly recovering. 
But these patients should be closely monitored for rejoining their coma, and in this 
situation, the antidote should be repeated. A surveillance period of at least 2 h after 
the last dose of naloxone is required to assert that the risk of recurrence of toxicity 
has passed [11].
Pulse oximetry is the recommended method to detect the presence of hypoxemia 
and to guide the administration of oxygen. Gasometry is a more accurate method 
for highlighting hypoxemia [4].
4. The poisoning effects on specific organ systems
4.1 Acute respiratory failure
Acute respiratory failure is a common condition for children with various intoxi-
cations to come into the PICU. Respiratory failure occurs due to central hypoventila-
tion, central nervous system depression, by the poisoning of central nervous system 
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depressants (barbiturates, opiates, alcohol, and tranquilizers), intoxication with 
organophosphate compounds, alkaloids, and atropine. Respiratory muscular paraly-
sis is another mechanism encountered in hemlock poisoning (Conium maculatum) 
and organophosphate. Mechanical ventilation disorders may occur during toxic sei-
zures [12, 13]. Airway obstruction through laryngeal edema is another mechanism of 
acute respiratory failure encountered in poisoning with corrosive or toxic acidic and 
toxic bases that cause anaphylactic shock, and obstruction through hypersecretion 
may occur in intoxication with sympathomimetic substances or organophosphate 
compounds. Acute toxic respiratory failure may also occur with acute pulmonary 
edema in alpha-naphthylthiourea (ANTU) intoxications, organophosphate com-
pounds, chlorine, carbon monoxide, ammonia, or hydrogen sulfide. Decreasing 
oxygenation capacity is another mechanism that can be produced by hemolysis in 
poisoning with saponin-containing plants or by methemoglobinemia or carboxy-
hemoglobinemia in nitrite/nitrate intoxication and carbon monoxide intoxication, 
respectively. The last mechanism consists in altering the oxidative tissue metabolism 
by inhibiting oxidative systems (cytochromes, cytochromoxidase) that may occur in 
cyanide, hydrogen sulfide, opaque, or fluorine intoxications [14].
As for the diagnosis of acute toxic respiratory insufficiency, in the initial phase, 
the signs and symptoms of background intoxication are highlighted. Once the 
respiratory failure has occurred, its symptoms, which are generally circumscribed 
to the pathophysiological mechanisms involved, become evident. In acute respira-
tory failure (ARF) from CNS disorders, consciousness status can be abolished and 
respiratory movements diminished in amplitude and frequency. The symptoms 
of ARF by affecting the resilient muscles are dominated by generalized muscular 
asthenia and dyspnea, and in the ARF by pulmonary damage, the tachypnea is more 
common. The clinical signs associated with hypercapnia and hypoxia in comatose 
patients are psychomotor agitation, dyspnea, and cyanosis [4]. However, the sever-
ity of cyanosis does not adequately reflect the severity of respiratory insufficiency. 
Increased intracranial pressure due to cerebral vasodilatation may result in cerebral 
edema, causing headache, obtundation, and even coma.
Blood gas analysis may reveal respiratory acidosis (pH < 7.35 and 
PaCO2 > 45 mmHg), which can be partially compensated by lowering the alkaline 
reserve and, in the absence of oxygen therapy, decreasing PaCO₂. A serious form of 
acute respiratory failure is acute respiratory distress syndrome (ARDS) manifested 
by bilateral pulmonary infiltration on radiography, PaO2/FiO2 ratio (partial oxygen 
pressure in arterial blood/oxygen fraction in the inspired air) below 200 mmHg and 
hemodynamic parameters within normal limits [12].
Corticosteroids and antibiotics may be used for the prophylactic purposes. 
Corticosteroids have been used for many toxic inhalational injuries. The prophylactic 
treatment of patients with inhalation injury with antibiotics has a empirical support 
[14, 15]. Essential therapy aims to ensure adequate blood oxygenation. Ensuring the 
ventilatory support should be seen in dynamics. Thus, ventilatory support begins 
with the least invasive supportive methods and progresses to the most aggressive 
techniques; you must minimize risks such as pneumothorax [16]. Oxygen supple-
mentation is indicated for patients with suspected or confirmed respiratory failure.
Approximately 10% of children admitted to the PICU for poisoning may require 
endotracheal intubation [6]. After the decision for mechanical ventilation has been 
made, the route needs to be selected. Some experts prefer oral intubation because it 
allows the use of a larger endotracheal tube—usually 8 mm or more in adults—than 
nasal intubation [17]. A wide range of equipment is necessary to allow for a wide 
range of patient size. A selection of both straight and curved blades should be avail-
able. Capnography should be available to assist the endotracheal tube placement in 
the airway.
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The goal of mechanical ventilation is to provide a sufficient exchange of oxy-
gen and carbon dioxide and the metabolic needs of a patient to be accomplished 
with minimum adverse effects [4]. The purpose of mechanical ventilation is not 
always to achieve the normal blood gas concentration. Given the predisposition to 
hypoventilation and the risk of acute pulmonary edema, the mechanical ventilation 
of patients intoxicated with salicylates requires a lot of attention [18, 19]. High-
frequency ventilation and ECMO should be considered to treat some severe intoxi-
cations, but there are limited reports on their use in pediatric toxicology [4, 20].
Noninvasive ventilation refers to providing the ventilation support without an 
invasive artificial path (intubation or tracheostomy probe). Patient selection is 
made taking into account noninvasive ventilation indications and contraindica-
tions as well as predictive factors of success or failure. Before starting noninvasive 
ventilation, a plan should be established to be applied if therapy fails. Noninvasive 
ventilation can be done with either portable CPAP or BiPAP devices that can also be 
used for home ventilation with either intensive ventilation or portable ventilation. 
One of the common causes of failure of noninvasive ventilation is the large air loss 
around to the ventilation mask [21].
4.2 Neurological complications
These are often the most prevalent symptoms in accidental or voluntary poison-
ings. Acute voluntary poisonings often involve psychotropic drugs (anxiolytic-
hypnotic, antidepressant, antipsychotic, etc.) or ethanol, whose central toxic 
target is the central nervous system. If the alteration of consciousness is a frequent 
complication of poisoning, mortality directly attributable to neurological impair-
ment is small compared to other etiologies (traumatic, vascular, etc.). Alteration of 
consciousness is most often due to a functional and reversible nature. It results from 
an interaction with one or more essential neurotransmitters (gamma-acidobutyric 
acid, serotonin, dopamine, etc.). However, lesional damage remains possible in case 
of exposure to a toxicant that prevents oxygen cellular use (e.g., carbon monoxide), 
when late detection or cardiopulmonary resuscitation complications cause anoxic or 
ischemic brain injury and ultimately neurovascular lesions [4, 22].
4.2.1 Acute alteration of consciousness
This is one of the most common pediatric emergencies. Its most serious form, 
coma, is one of the most critical situations faced by a doctor. Child coma occurs on 
an immature and fragile brain. In all cases of coma under the age of 7 years (includ-
ing accidental poisoning), there is a risk that child’s natural development achieve-
ments process will be compromised because the damage to the nervous system 
occurs during the full development process [23, 24]. The central nervous system 
(CNS), due to its rich lipid content and abundant vascularization is frequently the 
target organ for many toxic and nontoxic drugs. In intoxications, coma may occur 
due to direct toxic effects, metabolic abnormalities, or toxic-induced anoxia [25, 26].
The frequency of toxic coma varies in different studies, from 5% [26] to 28.9% 
[27]. In a recent prospective observational study, they accounted for 11.5% of all 
nontraumatic coma [28].
4.2.1.1 Anamnestic and clinical diagnosis of toxic comas
The toxic etiology of a coma must be raised in any patient who presents a severe 
deterioration of consciousness, without another obvious cause. In the absence 
of seizures, the patient often progresses to coma passing through the stages of 
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lethargy, confusion, and stupor. A carefully conducted anamnesis, taken from 
the caregivers, can sometimes indicate a poisoning. The child’s age can provide 
important information. Small children are prone to accidental poisoning, and in 
this situation, questioning the caregivers about toxic substances found in the house 
may be useful. Adolescents tend to experience alcohol, psychoactive substances, or 
recreational drugs. In the absence of an obvious history, toxicological exams need to 
be conducted in serum and urine [29, 30].
The physical examination can also provide clues about a possible intoxication. 
Thus, a careful examination of the teguments may reveal signs of venous punctures 
suggesting a drug self-injection, including heroin. Sclero-tegumentary jaundice 
may be highlighted, suggesting a hepatic failure of a toxic cause that has evolved 
into a coma. Epistaxis may exist in snorting cocaine. The presence of head lesions 
should alert the doctor about the possibility of a possible simultaneous cranial 
trauma [31]. The vital signs are also important for orientation toward a toxic etiol-
ogy. For example, benzodiazepines and opiates often cause respiratory depression. 
Amphetamines and cocaine can cause hypertension and tachyarrhythmias. Drugs 
that affect the autonomic nervous system may induce hyperthermia, vasoconstric-
tion or vasodilatation, and heart rhythm disorders [32].
Neurological examination is very important for the diagnosis (Figure 1). 
Evaluation of the coma is important in unconscious patients (Table 1). The general 
characteristics of toxic coma are the absence of meningeal signs and neurological 
focal signs, unless hypoglycemia is involved. During neurological examination, the 
plantar, deep tendon reflex, and muscle tone must be examined. Depending on the 
changes found, one of the following three syndromes can be outlined: pyramidal, 
extrapyramidal, or myorelaxation, which may indicate the toxins involved in 
inducing coma.
Figure 1. 
Neurological examination of the patient with toxic coma [33].
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Eye exams are essential for the toxic etiology. The type of coma associated with 
pupillary response may also suggest the toxin responsible for the coma appearance 
[33–35] (Figure 1). Periodic movement type “ping-pong” has been described in 
poisoning with monoamine oxidase inhibitors [34]. Hyperthermia is part of the 
anticholinergic syndrome; when associated with neurological disorders and toxic 
ingestion is not evident, then it is necessary to search for a cerebromeningeal infectious 
cause [31]. A convulsive coma may occur in the evolution of a poisoning with tricyclic 
antidepressants, phenothiazines, antihistamines, lithium, theophylline, carbamaze-
pine, dextropropoxyphene, amphetamines, cocaine, and hypoglycemic substances 
[35]. Coma associated with hemodynamic disorders can be found in meprobamate 
poisoning, membrane stabilizers, calcium inhibitors, or beta-blockers [4]. Detecting 
some breathing disorders associated with coma may be suggestive of some toxics. 
Decreased respiratory rate below 12 breaths/min, with regular breathing, indicates 
opioids or sedative hypnotics. Some sympathomimetic agents (salicylates, amphet-
amines, CO) on the contrary stimulate breathing, causing tachypnea. Kussmaul-type 
breathing (high frequency, regular) is usually associated with metabolic acidosis 
from poisonings with ethylene glycol, methanol, or salicylates [36, 37].
4.2.1.2 Laboratory investigations
Useful investigations into a toxic coma are mainly in serum determinations and 
much less often in neuroimaging investigations. Any metabolic acidosis in a toxic 
coma requires further investigation. The presence of low anionic gap suggests 
lithium or bromine intoxication. Highlighting an osmolar gap usually indicates a 
poisoning with ethanol, isopropanol, methanol, or ethylene glycol. Pure respira-
tory acidosis is consistent with hypoventilation, possibly a sign of poisoning with 
Area assessed Infant Children Score
Eyeopening Open spontaneously Open spontaneously 4
Open in response to verbal stimuli Open in response to verbal stimuli 3
Open in response to pain only Open in response to pain only 2
No response No response 1
Verbalresponse Coos and babbles Oriented, appropriate 5
Verbal response Confused 4
Cries in response to pain Inappropriate words 3
Moans in response to pain Incomprehensible words or nonspecific 
sounds
2
No response No response 1
Motor response Moves spontaneously and 
purposefully
Obeys commands 6
Withdraws to touch Localizes painful stimulus 5
Withdraws in response to pain Withdraws in response to pain 4
Responds to pain with decorticate 
posturing (abnormal flexion)
Responds to pain with decorticate 
posturing (abnormal flexion)
3
Responds to pain with decerebrate 
posturing (abnormal extension)
Responds to pain with decerebrate 
posturing (abnormal extension)
2
No response No response 1
Table 1. 
Modified Glasgow coma scale for infants and children.
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hypnotic sedatives or opioids. Although urinary toxicological tests may sometimes 
be useful in a toxic coma, the results are often false positive or false negative [24, 25].
Dosage of serum concentrations of some drugs is of great help, if available. 
Other useful investigations are the dosage of serum cholinesterases and carboxyhe-
moglobin. Coma caused by tricyclic antidepressants poisoning may be accompanied 
by electrocardiographic abnormalities (dysrhythmia) and seizures [38].
4.2.1.3 Treatment
The main life threat in toxic coma is the alteration of respiratory function. 
Therefore, maintaining airway permeability and ensuring effective breathing are 
a priority, because providing the O2 requirement of the brain is essential. In any 
suspicion of hypoxia or CO intoxication, O2 should be administered [32]. Not 
every child in a toxic coma should be intubated. It is estimated that orotracheal 
intubation is required in about 20% of toxic coma. The main indications are coma 
with alteration of swallow reflexes, acute respiratory failure unresponsive to O2 
administration, severe circulatory insufficiency or toxic comas associated with 
severe symptoms, refractory to pharmacological treatment (convulsions, hyper-
thermia) [33].
Glycemia should be measured as a matter of urgency, and if there is hypogly-
cemia, this must be quickly rectified. Activated charcoal gastrointestinal decon-
tamination can sometimes provide benefits, if done early. Gastric lavage can be 
performed if the patient has the respiratory tract protected by endotracheal tube. 
If the toxic is adsorbed on the activated charcoal, it can be administered by naso-
gastric tube. There is a lot of attention needed when administered to non-intubated 
patients. Hemodynamic instability induced by toxic shock, which may be hypovo-
lemic, distributive, or cardiogenic, requires vascular filling with saline or Ringer’s 
solution, injected quickly and possibly vasopressor medication. Any detected 
heart rhythm disorders and hypertension or hypotension need to be corrected. 
Simultaneously with the stabilization measures, the antidote will be administered 
according to the protocols in  toxic-induced coma [25].
In comas of unknown etiology, the concept of “coma cocktail” containing dex-
trose, oxygen, naloxone, and thiamine (vitamin B1) was proposed. But indications 
and efficiency were controversial.
Currently, in toxic comas, precise indications for flumazenil and naloxone are 
used. Flumazenil acts by a competitive mechanism at the benzodiazepine receptor 
level, canceling the sedation effects of benzodiazepines within 1–2 min of admin-
istration. In the case of children, we start with a dose of 0.01 mg/kg intravenously, 
which can be repeated 1–2 min to a total dose of 0.05 mg/kg maximum 1 mg. It is 
effective in toxic-induced coma by zolpidem and zopiclone. If in a calm coma of 
undetermined etiology, there is no patient awakening after the administration of 
flumazenil referred to dose, the diagnosis of intoxication with benzodiazepines 
is infirmed [39]. Naloxone is a pure opioid antagonist, which acts by competitive 
antagonism at μ receptors to determine the reversibility of respiratory depression, 
hypotension, and miotic within 2 min. For children >3 years, the indicated dose is 
0.01–0.1 mg/kg. If the desired effect is obtained, it may be repeated two times at an 
interval of 5 min; the dose may reach 10 mg. Regardless of the way of administra-
tion (intravenous, subcutaneous, intramuscular, endotracheal intubation probe, or 
inhalation), the effect is similar. The lack of response within 15 min after adminis-
tration requires looking for another coma cause [4, 5].
Extrarenal epuration may sometimes have indications in coma due to alcohol 
intoxications (ethylene glycol, isopropyl alcohol, and methanol), salicylates, 
theophylline, lithium, valproic acid, carbamazepine, or carbamates [40].
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4.2.1.4 Prognosis
The prognosis of toxic coma is generally better than that of anoxic coma. For 
example, in sedative poisoning, mortality is below 1%. The following neurological 
signs provide a poor prognosis for recovery from toxic coma: absence of corneal 
reflexes after day 1, absence of eye opening response on day 3, loss of pupillary 
reflexes (up to 1 week), lack of oculovestibular response, abnormal skeletal muscle 
tonus, the absence of spontaneous eye movement, the isoelectric pathway on the 
electroencephalogram [25].
Some toxic may cause prolonged coma (>100 h) with intermittent agitation 
periods known as cyclic coma: barbiturates, carbamazepine, clonazepam, ethchlor-
vynol, glutethimide, meprobamate, olanzapine, quetiapine. Short-term memory 
alteration and postcoma amnesia are possible, secondary to neuron damage in the 
pyramidal system at the hippocampus level in CO intoxication [25, 38].
4.2.2. Convulsions
Convulsions are common in situations when the toxic involved affects the cen-
tral nervous system. In the context of poisoning, seizures are often a sign of severity 
[41]. From the clinical point of view, toxic-induced convulsions can occur with or 
without warning signs (e.g., aura) or mental state alteration. Most toxic-induced 
seizures are generalized, tonic–clonic (“grand mal”). Epileptic status is defined as 
a continuous convulsive activity lasting more than 30 min or more convulsive epi-
sodes between which consciousness is not completely regained [4, 5, 42]. Patients 
with preexisting epileptogenic focal conditions may experience focal seizures [42].
4.2.2.1 Etiology of toxic seizures
Table 2 presents the etiology of toxic seizures.
4.2.2.2 Treatment of toxic seizures
Seizure control in PICU is a fundamental problem in the management of a poi-
soned child. Convulsions associated with toxic ingestion are sometimes difficult to 
control, being recurrent or persistent leading to status epileptics. This is associated 
with an increase in oxygen in the brain level. The imbalance between supply and 
demand can lead to cerebral ischemia. That is why an aggressive management of 
toxic seizures is critical to preventing brain damage. The first priority in managing 
seizure crises is to provide airway permeability and oxygen therapy to ensure deliv-
ery of oxygen to the brain. Evaluation and correction of electrolyte disturbances 
and hypoglycemia should also be promptly performed [4, 43]. The first therapeutic 
line for toxic-induced convulsions is represented by benzodiazepines (diazepam, 
lorazepam, or midazolam). Lorazepam and diazepam exhibit a similar clinical 
response time (until termination of seizure activity) [41, 42]. However, after treat-
ment with lorazepam, the rate of seizure recurrence appears to be lower [44]. Also, 
according to some studies, lorazepam has been shown to have a longer duration 
of action of the anticonvulsant effect (12–24 h vs. 15–30 min) and is therefore the 
preferred choice of some clinicians [42]. The preferred route of administration of 
benzodiazepines is intravenous. Table 3 lists the doses of benzodiazepines that can 
be used in toxic-induced convulsions in children and adolescents.
In the absence of response to benzodiazepines, phenobarbital or valproic acid 
may be effective for crises control. Phenytoin is less effective in the treatment 
of induced seizures [42]. If seizures do not stop at the referred medication, it is 
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necessary to induce coma with sodium thiopental or propofol. To induce a coma, 
sodium thiopental is administered as a bolus of 3 mg/kg, which is repeated after 
2 min, followed by maintenance with 1–15 mg/kg/h. For propofol, the dose is 
1–5 mg/kg bolus (repeatable) followed by continuous infusion up to a maximum 
Class Example(s) Class Example(s)
Pharmaceuticals Nonpharmaceuticals
Analgesics Meperidine/normeperidine, 
propoxyphene, pentazocine, salicylate, 
tramadol
Alcohols Methanol, ethanol 
(withdrawal)
Anesthetics Local anesthetics
(lidocaine, benzocaine)
Antiseptic/
preservatives
Ethylene oxide, phenol
Anticonvulsants Carbamazepine Biologic toxins
Antidepressants Tricyclic (amitriptilina/ nortriptyline), 
amoxapine, bupropion, selective 
serotonin reuptake inhibitors 
(citalopram), venlafaxine
Marine animals, 
mushrooms, 
plants
Domoic acid [shellfish 
(blue mussels)], 
monomethylhydrazine 
(Gyromitra spp.), coniine 
(poison hemlock), virol A 
(water hemlock), camphor
Antihistamines Diphenhydramine, doxylamine, 
tripelennamine
Gases (naturally 
and/or 
anthropogenically
occurring)
Carbon monoxide, hydrogen 
sulfide, cyanide
Antimicrobials Antibacterials (selected penicillins, 
cephalosporins, carbapenems, 
fluoroquinolones), antimalarials 
(chloroquine), tuberculostatics 
(isoniazid)
Metals/
organometallics
Alkyl mercurials 
(dimethylmercury), arsenic, 
lead, thallium, tetraethyl lead, 
organotins (trimethyltin)
Antineoplastics Alkylating agents (busulfan, 
chlorambucil)
Metal hydrides Pentaborane, phosphine
Antipsychotics Clozapine, loxapine Pesticides
Antiasthmatic Theophylline Fungicides/
herbicides
Dinitrophenol, diquat, 
glufosinate
Cardiovascular 
drug
Propranolol, quinidine Insecticides Organochlorines (DDT, 
lindane), organophosphates 
(parathion), pyrethroids 
(type II), sulfuryl fluoride, 
alkylhalides (methyl bromide)
Cholinergics Pilocarpine, bethanechol Molluscicides Metaldehyde
Muscle relaxants Baclofen, orphenadrine Rodenticides Strychnine, zinc, or aluminum 
phosphide
Nonsteroidal anti-
inflammatory 
drug
Mefenamic acid, phenylbutazone
Psychostimulant/
anorectics
Amphetamine, caffeine, 
cocaine, methamphetamine, 
3,4-methylenedioxymethamphetamine, 
synthetic cannabinoids
Vitamins/
supplements
Vitamin A, ferrous sulfate
Table 2. 
Proconvulsant agents (adapted after Hanson [44]).
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of 5 mg/kg/h [45]. A special category of seizure, which does not respond to tradi-
tional therapy, is that of isoniazid intoxication. In this case, the crises result from 
exhaustion of pyridoxine (vitamin B6) and respond only to its administration 
[4]. In case of intoxication with isoniazid, the vitamin B6 posology is 1 gram per 
gram of ingested isoniazid (maximum 5 grams). This dose will be given slowly 
within 10 min, or until seizures cease. If the seizures stop during administration, 
the remaining dose will be given within the next 4 h. If the dose of isoniazid is 
unknown, 70 mg/kg iv (maximum 5 g) should be administered in the same manner. 
The initial dose may be repeated once seizures relapse. Pyridoxine is also anticon-
vulsant therapy of choice in intoxication with gyromitra mushrooms in the dose of 
25 mg/kg iv in 10 min and can be repeated in case of seizure recurrence [41].
4.3 Cardiovascular disorders
These are a serious complication of some poisoning, requiring prompt monitor-
ing and treatment. Assessing a poisoned child at risk of cardiovascular disease 
requires a detailed physical exam. In addition to cardiac volume and output evalua-
tion, a series of laboratory tests must be performed: blood gases, electrolyte dosing, 
blood sugar, transaminases, and azote retention tests. In some cases, the serum level 
of the toxic substance can also be determined, which helps to assess the severity of 
intoxication and to support the therapeutic decision. Additional care management 
such as blood pressure measurement, electrocardiography, and echocardiography 
can also be useful to guide therapy in case of a poisoning accompanied by cardiovas-
cular instability. Identification of a certain toxic can simplify the treatment through 
specific intervention. If the poison is unknown, the initial resuscitation consists 
in administration of intravenous fluids to maintain a proper intravascular volume 
[4, 5]. Rapid administration of 20 ml/kg bolus isotonic fluids, usually crystalloid 
(normal saline or Ringer’s lactate) over 10–15 min, is used to restore intravascular 
volume. Additional fluid bolus may be required depending on the reassessment 
of intravascular volume [46]. However, the intravascular volume should be cor-
rected cautiously, because too vigorous expansion may lead to fluid retention, liver 
enlargement, signs of pulmonary edema, jugular vein distension, or cardiomegaly, 
without improvement of vital signs and tissue perfusion. Positively inotropic agents 
are required in such patients. The cardiovascular disorders, which are present at the 
time, determine which inotropic agents and vasopressor drugs to choose.
Arrhythmia is a frequent complication in cardiovascular drug poisoning. 
Dysrhythmia may occur by direct affecting of the electrical conduction system of 
the heart, by changing the electrical membrane potential across the myocardial cell, 
or by indirect disturbance of the electrical conduction system through the nervous 
system or due to electrolytic and metabolic disorders, which affect the electrical 
activity of the heart.
Benzodiazepine Pediatric dose
Lorazepam 0.05–0.1 mg/kg iv (maximum 4 mg/dose). It can be repeated at 10–15 min if necessary. 
Maximum dose: 8 mg/12 h
Diazepam <5 years: 0.2–0.5 mg/kg iv every 2–5 min up to a maximum total dose of 5 mg.
>5 years: 1–2 mg iv every 2–5 min up to a maximum total dose of 10 mg.
Midazolam >2 months: 0.15 mg/kg iv bolus, followed by a continuous infusion of 1 μg/kg/min, titrating 
the dose every 5 min until seizure control. Mean dose: 2–3 μg/kg/min.
Table 3. 
Posology of benzodiazepines in seizures in childhood (adapted after Blais and Dubé [41]).
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4.3.1 Bradyarrhythmias: etiology and treatment
Bradyarrhythmias occur due to some toxic substances, which decrease the central 
nervous system influx or the chronotropic activity of the conduction system. Agents 
that can induce bradyarrhythmias are tricyclic antidepressants, α2-adrenergic ago-
nists, β-adrenergic blockers, calcium channel blockers, cholinomimetics, digoxin, 
sedative hypnotics, organophosphorus and carbamates, plants containing cardiac 
glycosides, opioids, cocaine, organophosphorus, and carbamates [47].
Bradyarrhythmia due to ingestion of unknown toxic substance is managed with 
supportive treatment. Atropine or positive inotropic agents, such as epinephrine, 
are used to correct bradyarrhythmia. When the toxic agent is known, the aim of 
the therapy is to antagonize the toxic effects (e.g., calcium chloride is used to treat 
calcium channel blockers intoxication). Literature data showed that in poisoning 
with β-blocker, calcium channel blocker, and tricyclic antidepressant, glucagon 
may be used, given its positive inotropic and chronotropic effects. Glucagon dose 
in children is 0.03–0.15 mg/kg in 1–2 min bolus, followed by 0.07 mg/kg/h infu-
sion or by repeated boluses in 5–10 min, as needed [48]. Other therapies that may 
be used in severe β-blocker and calcium channel blocker poisoning are hyperinsu-
linemia—euglycemia (HIE) and intravenous fat emulsion (IFE) [49]. In bradycar-
dia mediated by vagal reflex, atropine is the treatment of choice. For unresponsive 
sinus bradycardia, as well as for junctional or ventricular bradyarrhythmias, iso-
proterenol may be used. Specific therapy should also be used (calcium in calcium 
channel blockers intoxication; digoxin antibodies in digoxin poisoning). Sodium 
bicarbonate is beneficial in tricyclic antidepressant poisoning. Concomitant cor-
rection of electrolyte disturbances, hypoxia, and acidosis is mandatory because 
they may contribute to failure of pacing stimulus to depolarize cardiac cells [47]. 
In severe cases of bradyarrhythmia or heart block unresponsive to pharmacological 
therapy, direct transthoracic pacing may be necessary.
4.3.2 Tachyarrhythmias
Tachyarrhythmias are common in poisonings. They are classified as wide-
complex and narrow-complex rhythm (Tables 4 and 5).
Electrocardiogram (ECG) in narrow-complex tachyarrhythmias shows sinus 
tachycardia or supraventricular tachycardia (normal conduction).
Specific therapies include antidotes depending on xenobiotic. Treatment imposes 
corrections of hypotension, hypoxia, or electrolyte abnormalities and administra-
tion of esmolol or other short-acting beta-blocker for intractable tachycardia in the 
absence of hypotension or other signs of myocardial depression [4, 47].
ECG in wide-complex tachyarrhythmias may show ventricular tachycardia (VT) 
monomorphic or polymorphic, ventricular fibrillation (VF), ECG signs preceding 
Anticholinergic: amantadine, antihistamines, atropine, belladonna, scopolamine, cyclic antidepressants, 
mushrooms (muscarine-containing, e.g., clitocybe dealbata), neuroleptics (thioridazines and mesoridazines 
also are membrane depressants), plants (e.g., Jimson weed)
Sympathomimetic: amphetamines and their congeners (e.g., ecstasy), caffeine, chloral hydrate, cocaine, 
ethanol, ephedrine and pseudoephedrine, lysergic acid diethylamide (LSD) and other hallucinogens, 
monoamine oxidase inhibitors, phencyclidine, scorpion or spider envenomation, sedative-hypnotic 
withdrawal, selective serotonin reuptake inhibitors, theophylline
Cholinomimetic: organophosphates
Table 4. 
Poisoning-induced narrow-complex tachyarrhythmias.
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VF/VT, supraventricular tachyarrhythmias, prominent R wave lead AVR, rightward 
deviation of QRS axis, and QT prolongation [47].
Correction of possible hydroelectrolytic and acido-basic imbalance is required in 
treatment of toxic ventricular tachycardia. In monomorphic ventricular tachycardia, 
if the patient’s condition is stable and there is no hemodynamic instability, chemical 
cardioversion with amiodarone 5 mg/kg iv, or procainamide 15 mg/kg iv or lidocaine 
1 mg/kg bolus is first attempted. In wide QRS complex tachycardias, adenosine is not 
useful. If the chemical cardioversion has results, the drug will be administered by con-
tinuous intravenous infusion to avoid relapses. The IV infusion time will be decided 
along with the pediatric cardiologist. If the chemical cardioversion is ineffective, 
synchronized biphasic electrical cardioversion with 0.5–1 J/kg is needed [47, 50]. In 
polymorphic ventricular tachycardia with hemodynamic instability, the treatment is 
based on electrical cardioversion associated with magnesium. If magnesium sulfate is 
ineffective or bradyarrhythmias occur, isoproterenol IV may be useful. Hypokalemia 
can exacerbate ventricular tachycardia, and therefore, potassium supplementation is 
required even in patients with normal potassium at the time of determination.
Bidirectional ventricular tachycardia is a hallmark of severe digitalis toxicity, 
and immediate specific antidote treatment with FAB antibodies must be started. 
This type of ventricular tachycardia may occur in aconite poisoning too [51, 52].
Torsades de pointes (TdP) is a specific type of polymorphic ventricular tachy-
cardia exhibiting a characteristic morphology on the electrocardiogram, in which 
the QRS complexes “twist” around the isoelectric line. This is a major toxin-induced 
arrhythmia, which may degenerate into ventricular fibrillation and sudden death 
[53, 54]. In this situation, the corrections of electrolyte disorders, bradycardia, 
acidosis, low blood pressure, and hypoxia are needed. If poisoning involves a drug 
with Na+ channel blocking properties (e.g., tricyclic antiarrhythmic drugs, cocaine, 
class IA and IC antiarrhythmic drugs, or antipsychotic drugs), sodium bicarbonate 
may be used to reduce the degree of sodium channel blockade by increasing extra-
cellular sodium [55]. The treatment of choice in torsade de pointes is magnesium 
sulfate. The pediatric dose is 25–50 mg/kg iv. If a poisoned patient does not respond 
to the abovementioned therapeutic measures, intravenous lipid emulsion therapy 
should be considered if the drug has lipophilic properties. A last therapeutic alter-
native is arteriovenous extracorporeal membrane oxygenation (ECMO) [47, 55].
5. Techniques for extrarenal treatment in toxicology
The Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup is a group of 
international experts spanning  disciplines of nephrology, toxicology, pediatrics, emer-
gency medicine, critical care, and clinical pharmacologists that has been reviewing the 
evidence in the literature and provide recommendations for the use of extracorporeal 
treatments in poisonings. To date, EXTRIP has published systematic reviews on the role 
of extracorporeal treatment (ECTR) for poisoning from acetaminophen, barbiturates, 
carbamazepine, digoxin, lithium, metformin, methanol, salicylates, thallium, theoph-
ylline, tricyclic antidepressants, and valproic acid [56]. Waste treatment methods are 
Antiarrhythmics (type Ia, Ic, III), antihistamines, arsenic, cardiac glycosides, cyclic antidepressants, 
carbamazepine, chloral hydrate
Other toxic: sodium fluoride, freon (and other fluorocarbon aerosols), hydrocarbon solvents, neuroleptics, 
propoxyphene, quinine, and related agents
Table 5. 
Poisoning-induced wide-complex tachyarrhythmias.
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numerous, and techniques and/or equipment continuously evolve. It mainly involves 
hemodialysis, hemoperfusion, hemofiltration, and albumin dialysis [57].
5.1 Hemodialysis
Hemodialysis is the technique of removing toxins from the blood using a diffu-
sion gradient through a semipermeable membrane. To be dialyzable, poisons must 
meet the following conditions: hydrosolubility, low molecular weight, apparent low 
volume of distribution, low protein binding, and low endogenous clearance [5]. 
It may be necessary in the following situations: severe poisoning with salicylates, 
accompanied by important mental disorders, in some phenobarbital intoxications, 
ethylene glycol, lithium, and theophylline [4, 6].
Possible complications of hemodialysis are hypotension, hypoxemia, bleeding, 
embolism, and cardiac rhythm disorders [4].
5.2 Hemoperfusion
The hemoperfusion column can be considered as an extracorporeal clear-
ance organ, increasing the overall clearance of the body. Its efficacy is superior to 
hemodialysis or hemofiltration. It has been proposed in serious poisonings with 
theophylline, carbamazepine, and cardiotoxic (membrane stabilizers, inhibitors 
calculation, and meprobamate) that do not quickly respond well to symptomatic 
treatment led. Its indication should be taken into account very early and in intoxica-
tions with some toxic lesions such as colchicine or paraquat [57]. Complications of 
hemoperfusion can be thrombocytopenia (30%), leukopenia (10%), hypocalcemia, 
hypoglycemia, reduction of fibrinogen, and hypothermia. The future lies in hemo-
perfusion devices coated with drug-specific antibodies or the antidote of the toxin 
instead of activated charcoal [58].
5.3 Hemofiltration and hemodiafiltration
Hemofiltration and hemodiafiltration have similar properties as hemodialysis 
regarding the distribution volume and protein-binding percentage. Water-like sub-
stances move out of the plasma through the membrane, and this fluid is replaced with 
isotonic fluids. The rate of removal of the toxin is influenced by the degree of protein 
binding and the ultrafiltration (UF) and the sieving coefficient, which is the ability 
of the solute to cross a membrane by convection. Although this makes high-efficiency 
convective techniques suitable for poisoning, reports of their use in poisoned patients 
remain limited due to their higher technical requirements and lesser availability [58, 59].
5.4 Other purification techniques used in toxicology
The most developed and most commonly used hepatic dialysis systems are the 
molecular adsorbent recirculation (MARS) and fractional plasma separation and 
absorption (Prometheus).
5.4.1 MARS albumin dialysis
MARS is a hemodialysis technique that combines the selective removal of albumin-
bound toxins with the removal of water-soluble toxins. The MARS system uses a 20% 
human albumin solution as a dialyzate and a semipermeable membrane as a dialyzer.
The albumin acquires an increased ability to bind toxins through contact with 
membrane’s polymers. Through the membrane, the patient’s blood comes into 
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contact with the albumin solution, and the albumin-related toxins cross the mem-
brane and enter the dialyzate, the transfer being made in the sense of the existing 
concentration gradient between the blood compartment and the albumin solution. 
After detoxification, the albumin solution is recirculated, coming into contact with 
the patient’s blood again [60–62]. Several small randomized controlled trials and 
case control studies in adults showed significant improvement, both in morbidity 
and mortality, in patients treated with MARS. However, there are little data on the 
use of MARS in the children [63].
5.4.2 The Prometheus system
It consists of a bloodstream where two filters perform a purification of water-
soluble toxins and then a fractional separation of plasma, so that cellular compo-
nents and macromolecules are separated by albumin and by low-molecular-weight 
solvents. Then, the autologous albumin solution crosses a neutral resin filter, which 
has an increased affinity for bile acids, aromatic amino acids, and phenols, and also 
an anion exchange resin filter that removes unconjugated bilirubin [64–66].
These techniques were initially used in hepatology. Subsequently, they were also 
used for the treatment of acute poisonings with or without liver failure, especially 
the MARS technique. The aim is to remove albumin-related toxic substances. 
There are several reports regarding the use of these purification techniques in high 
liver toxicity mushrooms poisoning as Amanita phalloides [60, 62, 64] and also 
in paracetamol poisoning [56, 60]. These techniques were also used to treat phe-
nytoin, theophylline, and diltiazem poisoning, and for calcium channel blockers 
poisoning too [57, 67].
5.4.3 Arteriovenous extracorporeal membrane oxygenation (ECMO)
ECMO is a special technique for maintaining pulmonary and cardiac function 
through an extracorporeal circulation pump. The purpose of this method is to pro-
vide a good oxygenation support and remove the excess of CO₂. It is an exceptional 
therapy proposed for serious poisonings, especially those that are complicated 
with respiratory distress syndrome or cardiogenic shock refractor on conventional 
therapy [68]. ECMO is difficult and should only be done in experienced centers 
as it carries significant risks. It is a method that requires systemic anticoagula-
tion. The main possible complications are bleeding, systemic infection, and 
thromboembolic accidents [4, 68]. If the ECMO indication has been established, 
this therapy should be initiated as soon as possible, before irreversible cerebral or 
visceral anoxic lesions [68, 69].
6. Organ donation
Despite the best efforts of the care team, it is not possible to save every child 
with poisoning. Particularly, in cases where there was significant hypoxic–ischemic 
central nervous system injury, patient may progress to brain death [70]. Because 
poisoning is not a sign of organ donation, these patients can be a potential donor 
source [71]. Toxicological risk assessment should be rigorously conducted in the 
sense that the transmission of intoxication to the recipient should be avoided. Some 
toxic substances accumulate in the liver, heart, or lung and could theoretically be 
released from these grafts after transplantation. These risks, however, should not be 
exaggerated. They can be diminished by knowledge of kinetics and toxics in target 
organs. Taking risks is more important for heart or kidney transplantation, organs 
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that are more susceptible to anoxic-ischemic damage [4–6]. Since severe depres-
sion of the central nervous system induced by some toxic can mimic brain death, 
it is important to allow sufficient time, depending on the pharmacology of the 
toxic substance, until the plasma concentration decreases to an acceptable level. To 
declare cerebral death, the following are necessary [4, 72, 73]:
• clinical criteria: deep, dormant coma, absence of brain stem reflexes, absence of 
spontaneous breathing;
• biological criteria:
 ○ mandatory: flat track on the EEG, apnea test, atropine test;
 ○ optional: cerebral angiography (stroke), transcranial echo-Doppler, scintig-
raphy, etc.
The conditions for declaring brain death vary according to the country’s legisla-
tion. Basically, the patient’s examination should be performed by two physicians: 
neurologist or neurosurgeon and anesthetist. In children, the intervals between 
examinations must be 24 h for the child aged 2 months to 1 year and at least 12 h 
over 1 year [74].
7. Conclusion
Complications of poisonings during childhood may enforce hospitalization to 
PICU and may contribute to lowering the survival rate. Supporting vital functions 
is the main objective of the management of a poisoned patient admitted in PICU.
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